Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.00 0.68% 148.50 145.00 152.00 152.00 146.00 147.50 286,981 14:47:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 6.1 -13.9 -35.9 - 84

Reneuron Share Discussion Threads

Showing 8151 to 8174 of 8300 messages
Chat Pages: 332  331  330  329  328  327  326  325  324  323  322  321  Older
DateSubjectAuthorDiscuss
16/1/2021
13:13
The new approach was suggested by Prof Rob Maclaren, I believe. Rather than lifting the viable part of the retina which temporarily denies nutrients to the receptors, the hRPC cells are injected at the periphery in the non-viable tissue. The hypothesis is that the hRPC cells will migrate across the retina and integrate into the viable retinal tissue.
whatno
16/1/2021
11:36
Thanks both. Had a look at the Jan presentation. I also learned a new word, bleb.
hashertu
15/1/2021
21:54
And a transcript apparently
the stigologist
15/1/2021
18:30
hashertu - I picked up the information on the Investor Conference call a few days ago. There is a recording on their website.
pdt
15/1/2021
17:39
PDT. Post 7892. Do you have any more information about the revised study protocol?
hashertu
15/1/2021
15:22
What's all those trades about at £1.35? At that time they drop it and low and behold a load of big buys pop through a bit later.See this on a few shares recently.
gf123
15/1/2021
15:11
A good update, nice to see progress according to plan. In addition I believe they were using a different technique to place the cells in the eye. Presumably that has gone well so far. Once they have completed the safety review in a few weeks time they can recruit and treat the remaining 6 patients relatively quickly.
pdt
15/1/2021
13:31
Charts will tell you that, sometimes the tide comes in... sometime later it goes out again. Best thing is learn to swim.
deutsch4
15/1/2021
13:20
What he said
volsung
15/1/2021
12:43
htTps://twitter.com/hareng_rouge/status/1348748130427285504?s=20
the stigologist
15/1/2021
12:37
Myles McNulty is probably the reason for the rise today, he has a big following: hTTps://twitter.com/MylesMcNulty/status/1350001572584026112
homebrewruss
15/1/2021
12:36
Clear technical breakout now I think we look very similar to March 2019... And April 2019 was INCREDIBLE
the stigologist
15/1/2021
12:29
Yes. I wonder if US investors will start getting involved here CDAK Codiak Mkt Cap $500m RENE Mkt Cap is £70m (with £20m cash so EV £50m) This has almost overnight become a mRNA and CRISPR play
the stigologist
15/1/2021
11:30
Those comments from Hrouge on twitter are a clue. check out CRISPR tech stocks such as Intellia and their price action over the last year. Exosome technology is in the mix with these companies and these companies are potentially game changers for medicine.
grum3still
15/1/2021
10:49
Up 12% apart from RNS any other reason. Seems a late reaction if it's just the rns
ayl30
15/1/2021
10:06
Bought in again. Maybe this time Rodders - next year?
volsung
15/1/2021
10:02
Ouch I feel sorry for anybody who was the wrong end of that 2007 spike. Still given the relatively tiny mcap here for a pharma this could 10 bag and still look very cheap.
katsy
15/1/2021
09:15
Myle McNulty positive targeting 700p within 24-36 months
the stigologist
15/1/2021
09:02
Building up position here.
someuwin
15/1/2021
08:53
Good update. As always, these biotech innovations take a long time, but the potential here is massive in the RP alone.
small crow
14/1/2021
17:38
Another inside day and consolidation above the breakout level
the stigologist
13/1/2021
16:30
Good inside day
the stigologist
12/1/2021
21:40
RENE Nice breakout
the stigologist
12/1/2021
17:07
Someone very keen to get on board before this train leaves the station
the stigologist
Chat Pages: 332  331  330  329  328  327  326  325  324  323  322  321  Older
ADVFN Advertorial
Your Recent History
LSE
RENE
Reneuron
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210506 14:09:21